Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00992277 · ClinicalTrials.gov registry record · Phase 2
In-vivo Analysis and Clinical Evaluation of the Performance of a Fractional CO2 Laser System (eMatrixCO2)
A Phase 2 study, sponsored by Syneron Medical.
- Completed
- Registry status
- Phase 2
- Development phase
- 25
- Enrollment target
NCT00992277 is a Phase 2 study that has completed, run by Syneron Medical. The registered enrollment target is 25 participants.
The verdict
NCT00992277, a Phase 2 study, has completed, sponsored by Syneron Medical.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 25 participants
- Enrollment target
Study Summary
This study will: Evaluate the in vivo histological and molecular effects of treatment with eMatrixCO2 and to determine the dynamics of their development over time following treatment. Determine the safety and efficacy of treatment with eMatrixCO2 for use in Aesthetic dermatological procedures requiring the ablation, vaporization, excision, incision, or coagulation of soft tissue.
Interventions
- PROCEDURE Ablation and skin resurfacing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2009-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00992277
The ClinicalTrials.gov registry entry for NCT00992277 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Syneron Medical, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ablation and skin resurfacing is the first listed.
NCT00992277 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00992277 about?
NCT00992277 is a clinical study titled "In-vivo Analysis and Clinical Evaluation of the Performance of a Fractional CO2 Laser System (eMatrixCO2)". This study will: Evaluate the in vivo histological and molecular effects of treatment with eMatrixCO2 and to determine the dynamics of their development over time following treatment. Determine the safety and efficacy of treatment with eMatrixCO2 for use in Aesthetic dermatological procedures requ...
What is the current status of trial NCT00992277?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 25 participants. The study started on 2009-10.
What interventions are being tested in trial NCT00992277?
The interventions under investigation include: Ablation and skin resurfacing (PROCEDURE).
Who is sponsoring clinical trial NCT00992277?
This trial is sponsored by Syneron Medical, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.